Hypertension in young adults with obesity: new mechanisms and therapeutic options

Hypertension is a leading global cause of morbidity and mortality, increasingly prevalent among young adults with obesity. This epidemiologic shift is particularly concerning, as early‑onset hypertension confers an increased lifetime risk of cardiovascular disease. Obesity and hypertension share pathophysiological mechanisms, including sympathetic nervous system overactivation, leptin resistance, chronic low‑grade inflammation, renal fat deposition, endothelial dysfunction, and genetic predisposition. Dietary factors, sedentary lifestyle, poor sleep, psychosocial stress, and environmental exposures further exacerbate the risk. Hence, effective management requires an integrated approach targeting both obesity and blood pressure. Lifestyle interventions play a key role in therapy but are often hindered by poor adherence in younger populations. Pharmacological therapies have shown substantial efficacy in reducing weight and blood pressure, with emerging cardiovascular benefits. Bariatric surgery remains an alternative, achieving sustained weight loss and remission of hypertension in a significant proportion of patients. Early, multifaceted interventions tailored to this population can reduce premature cardiovascular disease, lower health care costs, and improve quality of life.